Mol Psychiatry · 2026
Efficacy and safety of pharmacological treatments in borderline personality disorder: A systematic review and network meta-analysisConclusion: Conversely, alprazolam, methylphenidate, haloperidol, and valproate had only low-certainty evidence in unselected BPD samples and should not be prioritised. Prescription should be limited to specific, individualised indications, such as panic, comorbid ADHD, or transient psychotic features, following cautious clinical appraisal.